Home » Business » Business news live: Rachel Reeves in savings tax crackdown and mortgage lender launches new 3.8% offer

Business news live: Rachel Reeves in savings tax crackdown and mortgage lender launches new 3.8% offer

by Priya Shah – Business Editor

“`html

Jameson Hayes8 August 2025 10:35

Bitcoin Surges Past $116,000 Amidst 401(k) Inclusion; Gold Nears $3,500

Bitcoin experienced a rally,climbing to $116,500 after a recent dip to around $112,000,representing a 1.2% increase in the last 24 hours. This upward momentum follows a decision by the management of US President Donald Trump to permit the inclusion of cryptocurrencies in 401(k) retirement plans.

The executive order, signed on August 7th, 2025, allows for the investment of digital assets within tax-advantaged retirement accounts, potentially opening up a new avenue for mainstream adoption.The Department of Labor is expected to issue clarifying guidance within 60 days regarding permissible crypto assets and custodial requirements.

Concurrently, gold prices rose 1% to $3,488, fueled by the implementation of tariffs on imported gold bars announced by the US Treasury Department on August 5th. Analysts at Goldman Sachs predict gold could reach $4,000 per ounce by the end of the year, citing geopolitical instability and continued inflationary pressures.

Brent crude oil saw a modest increase of 0.2% to $66.58 per barrel, remaining below the two-month average price. Supply concerns related to ongoing tensions in the South China Sea are being monitored by the Energy Information Administration (EIA).

Jameson Hayes8 August 2025 11:15

GSK Secures $500 Million Settlement in Covid Vaccine Patent Dispute with CureVac

Pharmaceutical giant GlaxoSmithKline (GSK),headquartered in Brentford,England,is set to receive up to $500 million (£372 million) following the resolution of a patent dispute concerning its Covid-19 vaccine growth. The settlement agreement was reached with German biotechnology company CureVac in the US District Court for the District of Delaware.

GSK will initially receive a $370 million (£275 million) payment from CureVac, stemming from their collaborative work on mRNA vaccine technology. The original

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.